| Healthy controls | FTLD |
---|
| | FTLD PGRN- | FTD PGRN+ |
---|
Total number | 59 | 78 | 14 |
Gender (female), % | 57 | 44 | 60 |
Age, years | 65.2 ± 1.0 | 65.5 ± 0.8 | 63.3 ± 2.3 |
Diagnosis, bvFTD/PPA, % | - | 75.6/24.4 | 71.4/28.6 |
MMSE, score | 29.1 ± 0.13 | 21.3 ± 0.8* | 18.5 ± 3.0* |
Progranulin, ng/ml | n.a. | 179.7 ± 6.6 | 63.4 ± 9.2** |
- FTLD: frontotemporal lobar degeneration; PGRN-: no progranulin pathogenetic mutations; PGRN+: progranulin pathogenetic mutations.
- Results are expressed as mean ± SEM (standard error), or otherwise specified. n.a.: not available
- * P < 0.0001, significantly different from healthy control subjects
- ** P < 0.0001, significantly different from FTLD